Cas:36461-20-8 2-morpholin-4-ylcyclobutan-1-one,hydrochloride manufacturer & supplier

Chemical Name:2-morpholin-4-ylcyclobutan-1-one,hydrochloride

CAS.NO:36461-20-8

Synonyms:2-Morpholin-4-yl-cyclobutanone, hydrochloride;2-Morpholino-cyclobutanone Hydrochloride;2-Morpholinocyclobutanone hydrochloride;2-morpholin-4-ylcyclobutan-1-one, hydrochloride

Molecular Formula:C₈H₁₄ClNO₂

Molecular Weight:191.65500

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:29.54000

Exact Mass:191.07100

LogP:0.79000

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 2-Morpholin-4-yl-cyclobutanone, hydrochloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-morpholin-4-ylcyclobutan-1-one, hydrochloride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Morpholinocyclobutanone hydrochloride Use and application,2-morpholin-4-ylcyclobutan-1-one, hydrochloride technical grade,usp/ep/jp grade.

Related News: It wasn’t known if this was due to racial differences in breast cancer-related genetic mutations, making it unclear whether race should help guide genetic testing. 2-morpholin-4-ylcyclobutan-1-one,hydrochloride manufacturer The two trials studied similar patient populations, Tendler said, but VMP was an old standard of care that’s not really used today in the U.S. Still, Tendler believes the two regimens may both have roles to play based on each patient’s ability to tolerate them. Whichever cocktail physicians choose, the two phase 3 studies have confirmed the benefit of Darzalex in transplant-ineligible patients, he added. 2-morpholin-4-ylcyclobutan-1-one,hydrochloride supplier It wasn’t known if this was due to racial differences in breast cancer-related genetic mutations, making it unclear whether race should help guide genetic testing. 2-morpholin-4-ylcyclobutan-1-one,hydrochloride vendor Taking Minuo Huawei as an example, in 2016, the capacity utilization rate and production-sales ratio of its multiple drug substance varieties reached more than 90%. Therefore, domestic API companies have expanded their production capacity in recent years to meet the growing demand for APIs. 2-morpholin-4-ylcyclobutan-1-one,hydrochloride factory It wasn’t known if this was due to racial differences in breast cancer-related genetic mutations, making it unclear whether race should help guide genetic testing.